Name: SAS / DOX @ OHS-PEG
Composition: Sulfonazine (SAS) + Dxorubicin (DOX) + C sphere PEG Ag
Size: 200-500nm
Application: Ion visual sensing
Storage conditions: -4℃
Other instructions: shelf life of half a year in sealed state [Main advantages] SAS / DOX @ OHS-PEG can reach the tumor site through the well-known enhanced permeability and retention (EPR) effect and release SAS and DOX stimulated by high concentration of glutathione (GSH) at the tumor site. As a sulfonamide antimicrobial aging drug, SAS can inhibit the expression of cystine / glutamate transporter (xCT), leading to the reduction of glutathione peroxidase 4 (GPX 4) synthesis content, leading to iron apoptosis of tumor cells. Meanwhile, the classical chemotherapeutic drug DOX induced pyroptosis through caspase-3-dependent lysis of gasderin E (GSDME).
Title:Ferroptosis and Pyroptosis Co-Activated Nanomodulator for “Cold” Tumor Immunotherapy and Lung Metastasis Inhibition
Article link:https://doi.org/10.1002/adfm.202211698
Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
|
Scan code concerns WeChat official account
QQCommunication group:1092348845
|
|
Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |